Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
PLoS One ; 15(2): e0229021, 2020.
Article in English | MEDLINE | ID: mdl-32032364

ABSTRACT

BACKGROUND: The nasopharynx can from time to time accommodate otherwise pathogenic bacteria. This phenomenon is called asymptomatic carriage. However, in case of decreased immunity, viral infection or any other enhancing factors, severe disease can develop. Our aim in this study was to survey the nasal carriage rates of four important respiratory pathogens in three different age groups of children attending nurseries, day-care centres and primary schools. This is the first study from Hungary about the asymptomatic carriage of H. influenzae and M. catarrhalis. METHODS: Altogether 580 asymptomatic children were screened in three Hungarian cities. Samples were collected from both nostrils with cotton swabs. The identification was based on both colony morphology and species-specific PCRs. Serotyping was performed for S. pneumoniae, H. influenzae and M. catarrhalis. Antibiotic susceptibility was determined with agar dilution, according to the EUCAST guidelines. Clonality was examined by PFGE. RESULTS AND CONCLUSIONS: Whereas the carriage rates of S. pneumoniae, H. influenzae and M. catarrhalis clearly decreased with age, that of S. aureus showed an opposite tendency. Multiple carriage was least prevalent if S. aureus was one of the participants. The negative association between this bacterium and the others was statistically significant. For pneumococcus, the overall carriage rate was lower compared to earlier years, and PCV13 serotypes were present in only 6.2% of the children. The majority of H. influenzae isolates was non-typeable and no type b was detected; serotype A was dominant among M. catarrhalis. All four bacteria were more sensitive to antibiotics compared to clinical isolates. No MRSAs were detected, but we found three mupirocin resistant strains. The positive effect of Hib- and PCV-vaccination is undoubted. Continued surveillance of these pathogens is required.


Subject(s)
Carrier State/epidemiology , Carrier State/microbiology , Haemophilus influenzae , Moraxella catarrhalis , Nasopharynx/microbiology , Staphylococcus aureus , Streptococcus pneumoniae , Adolescent , Age Factors , Anti-Bacterial Agents/pharmacology , Child , Child, Preschool , Coinfection/epidemiology , Coinfection/microbiology , Female , Haemophilus Infections/epidemiology , Haemophilus Infections/microbiology , Haemophilus influenzae/classification , Haemophilus influenzae/drug effects , Haemophilus influenzae/genetics , Haemophilus influenzae/isolation & purification , Humans , Hungary/epidemiology , Infant , Male , Microbial Sensitivity Tests , Moraxella catarrhalis/classification , Moraxella catarrhalis/drug effects , Moraxella catarrhalis/genetics , Moraxella catarrhalis/isolation & purification , Moraxellaceae Infections/epidemiology , Moraxellaceae Infections/microbiology , Pneumococcal Infections/epidemiology , Pneumococcal Infections/microbiology , Public Health Surveillance , Risk Factors , Serogroup , Staphylococcus aureus/classification , Staphylococcus aureus/drug effects , Staphylococcus aureus/genetics , Staphylococcus aureus/isolation & purification , Streptococcus pneumoniae/classification , Streptococcus pneumoniae/drug effects , Streptococcus pneumoniae/genetics , Streptococcus pneumoniae/isolation & purification
2.
Vaccine ; 37(1): 99-108, 2019 01 03.
Article in English | MEDLINE | ID: mdl-30470639

ABSTRACT

Young children - the main asymptomatic carriers of pneumococcus - are often the source of pneumococcal infections. PCV13 replaced PCV7 in 2010 in Hungary and it became a mandatory vaccine in 2014. In this work we surveyed the effect of vaccination in three groups: in healthy children under 7 years; in children of the same age but infected with pneumococcus (P1); in older patients (P2) who were very likely not vaccinated. Nasal swabs were taken from 522 healthy children to screen pneumococcal carriage between March 2015 and May 2016. In the same time period, 146 clinical isolates were collected, mainly from mucosal infections. Serotypes, antibiotic susceptibility and clonality of the isolates was determined and compared. The carriage rate was 39.1%. Regarding carriage, the serotype distribution showed the total disappearance of serotypes 3 and 6A compared to former Hungarian studies. The prevalence of PCV13 serotypes was only 5.8% represented by three serotypes (19F, 19A, 9V). Of note, serotype 19A (a very resistant and invasive type) also decreased significantly. In the patient groups, PCV13 prevalence was higher: 17.5% (P1) and 32.6% (P2). Although serotype 3 was present in P1 (7.9%), the leading serotype was 23B (22.2%), a non-vaccine type (NVT). P2 showed the most diverse serotype distribution, but serotype 3 was predominant here (15.7%). Pneumococcal isolates from the patients were more resistant towards the tested antibiotics compared to those from carriers. PCV13 seems to be highly successful in reducing the prevalence of vaccine serotypes. The serotype-rearrangement can be seen also among clinical isolates, albeit somewhat later in time. Fortunately, the replacing serotypes are less invasive and less resistant, but, most worrisome, serotype 19F can be found again with increased frequency among carriage isolates and mucosal infections. Further surveillance is needed to carefully monitor such successful, antibiotic resistant "refugees".


Subject(s)
Carrier State/microbiology , Pneumococcal Infections/microbiology , Serogroup , Streptococcus pneumoniae/classification , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/pharmacology , Carrier State/epidemiology , Child , Child, Preschool , Drug Resistance, Bacterial , Female , Heptavalent Pneumococcal Conjugate Vaccine/immunology , Heptavalent Pneumococcal Conjugate Vaccine/therapeutic use , Humans , Hungary/epidemiology , Infant , Infant, Newborn , Male , Microbial Sensitivity Tests , Middle Aged , Nasopharynx/microbiology , Pneumococcal Infections/epidemiology , Pneumococcal Vaccines/immunology , Pneumococcal Vaccines/therapeutic use , Streptococcus pneumoniae/drug effects , Young Adult
3.
Infection ; 46(6): 855-860, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30191513

ABSTRACT

To describe the characteristics of adult invasive H. influenzae disease, 34 patients diagnosed at a single tertiary center between 2004 and 2017 were analyzed in a retrospective case series study. The annual estimated incidence was 0.1 cases/100.000 inhabitants. Dominant source of infection was pneumonia accompanied by sepsis (62%) and caused by nontypeable strains (74%) with low ampicillin resistance (14%). Survival (94%) and complication rates were high (35%). Main empirical treatments were ceftriaxone or levofloxacine.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Drug Resistance, Bacterial , Haemophilus Infections/epidemiology , Haemophilus influenzae/physiology , Sepsis/epidemiology , Adult , Aged , Aged, 80 and over , Ampicillin/therapeutic use , Ceftriaxone/therapeutic use , Female , Haemophilus Infections/complications , Haemophilus Infections/diagnosis , Haemophilus Infections/microbiology , Haemophilus influenzae/drug effects , Humans , Hungary/epidemiology , Incidence , Levofloxacin/therapeutic use , Male , Middle Aged , Retrospective Studies , Sepsis/diagnosis , Sepsis/microbiology
4.
Int J Med Microbiol ; 307(8): 431-434, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29089242

ABSTRACT

We have screened 2568 healthy individuals (mostly children) for Staphylococcus aureus and Streptococcus pneumoniae nasal carriage between 2010 and 2012. Out of the isolated 751 S. aureus strains, we found one methicillin-sensitive catalase-negative S. aureus (CNSA). Our CNSA isolate possessed a novel nonsense point mutation in the katA gene leading to early truncation of the protein product. The strain was resistant to penicillin and erythromycin, but sensitive to all other tested antibiotics and carried the enterotoxin A gene. It belonged to sequence type 5 (ST5), which is a successful, worldwide spread, usually MRSA clone. Catalase has been described as a virulence factor strictly required for nasal colonisation, and this is the first case contradicting this theory, as all previous CNSA isolates derived from infections. This is the first report of a CNSA from a symptomless carrier as well as the first occurrence in Hungary.


Subject(s)
Acatalasia , Carrier State/microbiology , Codon, Nonsense , Staphylococcal Infections/microbiology , Staphylococcus aureus/enzymology , Staphylococcus aureus/genetics , Child , Child, Preschool , Female , Genotype , Humans , Hungary , Male , Microbial Sensitivity Tests , Molecular Typing , Nasal Cavity/microbiology , Staphylococcus aureus/drug effects , Staphylococcus aureus/isolation & purification , Young Adult
5.
Acta Microbiol Immunol Hung ; 64(1): 1-7, 2017 Mar 01.
Article in English | MEDLINE | ID: mdl-28220707

ABSTRACT

A Hungarian soldier previously immunized against Neisseria meningitidis by quadrivalent polysaccharide vaccine was twice infected with meningococci within six weeks. The patient was treated with ceftriaxone during both episodes and he successfully recovered. His close contacts received rifampicin prophylaxis. An investigation was performed to characterize the genetic background of the pathogens to ascertain if the recurrent invasive meningococcal disease was caused by the same strain and to find out the reason for reinfection. Both meningococci belonged to the fine type Y:P1.5-2,10-1:F4-1:ST-23. This is the first description of the Europe-wide prevalent N. meningitidis serogroup Y in Hungary. In the first episode, we found wild-type rpoB allele in the non-culturable sample implying the susceptibility to rifampicin. The culturable isolate from the second episode proved resistant to rifampicin and had a point mutation in the rpoB gene. The rifampicin resistance might have evolved during the prophylactic treatment of contacts. Previous immunization of the patient with polysaccharide vaccine was ineffective due to his immunodeficiency, thus immunization with conjugate vaccine was proposed. We have proposed the implementation of centralized rifampicin susceptibility testing of N. meningitidis strains within a defined time frame to intervene and administer appropriate prophylaxis to close contacts.


Subject(s)
Anti-Bacterial Agents/pharmacology , Drug Resistance, Bacterial , Neisseria meningitidis, Serogroup Y/isolation & purification , Rifampin/pharmacology , Genotype , Humans , Hungary , Male , Neisseria meningitidis, Serogroup Y/drug effects , Neisseria meningitidis, Serogroup Y/genetics , Serogroup , Young Adult
6.
Eur J Pediatr ; 174(3): 373-81, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25178897

ABSTRACT

UNLABELLED: Streptococcus pneumoniae is responsible for a significant amount of morbidity and mortality worldwide. Healthy carriers, mainly young children, are the most important sources of infections. In the current study, we aimed to determine the changes that have occurred since the introduction of PCV-7 in Hungary. Nasal specimens were collected from 1,022 healthy children aged 3-6 years attending day-care centres. After thorough identification, pneumococcal isolates were serotyped, and their antibiotic sensitivity was determined. The carriage rate was found to be 34.9%. A huge serotype rearrangement was detected compared to earlier results, with the previously leading serotype 14 having completely disappeared. Serotypes 11A, 35F, 19A, 6B, 15B, 3 and 38 were most prevalent, and 29 different types were identified in total. The PCV-7 types were responsible for 16.5% of all serotypes, and 36.0% are not covered by any pneumococcal vaccines. The isolates were sensitive to most tested antibiotics, except erythromycin (resistance was 21.6%). Only one penicillin-resistant strain was found. The newly and rapidly emerging non-vaccine serotypes are much more sensitive, except serotype 19A. CONCLUSION: Due to PCV vaccination, a complete serotype arrangement occurred also in Hungary. The old "paediatric" serotypes were replaced by serotypes 11A, 35F, 19A, 6B, 15B, 3 and 38.


Subject(s)
Pneumococcal Vaccines/immunology , Streptococcus pneumoniae/immunology , Vaccines, Conjugate/microbiology , Child , Child, Preschool , Female , Humans , Hungary , Male , Nasopharynx/microbiology , Pneumococcal Vaccines/blood , Serogroup , Streptococcus pneumoniae/isolation & purification , Vaccination/methods , Vaccines, Conjugate/classification
7.
Int J Food Microbiol ; 112(1): 71-4, 2006 Oct 15.
Article in English | MEDLINE | ID: mdl-16934896

ABSTRACT

Food samples were monitored for contamination with Listeria monocytogenes, and the incidence of human listeriosis was evaluated according to the data obtained in Hungary in the year 2004. Of the food samples tested, the bacterium was most often detectable in milk and dairy products, as 72.1% of all L. monocytogenes strains were isolated from these samples. The food samples most commonly yielded strains of serotype 1/2a (45.1%) and 4b (27.0%). In 2004, 3 perinatal and 14 nonperinatal human listeriosis cases were diagnosed in Hungary. These disease cases were most often caused by strains belonging to serotype 4b (52.8%) and serotype 1/2a (23.5%). On the basis of the antibiotic sensitivity test results of strains isolated from the disease cases, penicillin and aminoglycoside antibiotics or a combination thereof were found to be effective.


Subject(s)
Anti-Bacterial Agents/pharmacology , Food Contamination/analysis , Listeria monocytogenes/isolation & purification , Listeriosis/epidemiology , Adult , Aged , Aged, 80 and over , Drug Resistance, Bacterial , Female , Humans , Hungary/epidemiology , Incidence , Listeria monocytogenes/classification , Listeriosis/drug therapy , Male , Microbial Sensitivity Tests , Middle Aged , Sentinel Surveillance , Serotyping
SELECTION OF CITATIONS
SEARCH DETAIL
...